TGFB1 and neoplasm: By employingan SMA-560 mouse glioma model, Tran et al. [37] have shown that inhibition of TGF-β signaling by the TGF-β RIkinase inhibitor SX-007 increased T-cell (CD3+) infiltration into the tumor.